Commonwealth of Pennsylvania Public School Employees Retirement System’s Neurocrine Biosciences NBIX Stock Holding History

Commonwealth of Pennsylvania Public School Employees Retirement System’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.06M	Sell	24,072 -1,074	-4%	-$159K	0.02%	527
2026 Q1	$3.31M	Buy	25,146 +195	+0.8%	+$25.9K	0.02%	628
2025 Q4	$3.54M	Sell	24,951 -504	-2%	-$73K	0.02%	603
2025 Q3	$3.57M	Buy	25,455 +28	+0.1%	+$3.79K	0.02%	602
2025 Q2	$3.2M	Buy	25,427 +1,594	+7%	+$183K	0.02%	597
2025 Q1	$2.64M	Buy	23,833 +1,472	+7%	+$186K	0.02%	633
2024 Q4	$3.05M	Buy	22,361 +103	+0.5%	+$12.7K	0.02%	576
2024 Q3	$2.56M	Sell	22,258 -48	-0.2%	-$6.58K	0.02%	621
2024 Q2	$3.07M	Buy	22,306 +294	+1%	+$40.3K	0.02%	524
2024 Q1	$3.04M	Buy	22,012 +332	+2%	+$45.3K	0.02%	539
2023 Q4	$2.86M	Buy	21,680 +1,905	+10%	+$219K	0.02%	522
2023 Q3	$2.22M	Sell	19,775 -27,392	-58%	-$2.88M	0.02%	570
2023 Q2	$4.45M	Buy	47,167 +3,663	+8%	+$358K	0.03%	421
2023 Q1	$4.4M	Buy	43,504 +257	+0.6%	+$26.7K	0.04%	380
2022 Q4	$5.17M	Buy	43,247 +5,328	+14%	+$624K	0.04%	315
2022 Q3	$4.03M	Buy	37,919 +82	+0.2%	+$8.32K	0.04%	329
2022 Q2	$3.69M	Buy	37,837 +3,069	+9%	+$283K	0.04%	371
2022 Q1	$3.26M	Buy	34,768 +3,315	+11%	+$281K	0.03%	480
2021 Q4	$2.68M	Buy	31,453 +185	+0.6%	+$17K	0.03%	590
2021 Q3	$3M	Sell	31,268 -229	-0.7%	-$21.6K	0.03%	465
2021 Q2	$3.06M	Buy	31,497 +156	+0.5%	+$15K	0.03%	485
2021 Q1	$3.05M	Buy	+31,341	New	+$3.29M	0.04%	457
2013 Q3	–	Sell	-22,085	Closed	-$295K	–	1354
2013 Q2	$295K	Buy	+22,085	New	+$271K	0.01%	1213

Other funds holding NBIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Commonwealth of Pennsylvania Public School Employees Retirement System's NBIX Position: Q2 2026 in Review

Commonwealth of Pennsylvania Public School Employees Retirement System reduced its Neurocrine Biosciences (NBIX) stake by 4.3% in Q2 2026, selling an estimated $159K and leaving 24,072 shares worth $4.06M. The position accounts for 0.02% of the portfolio, ranked #527.

Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in NBIX in Q2 2013 and has held it in 23 quarters since. The position peaked at $5.17M in Q4 2022. 772 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

Commonwealth of Pennsylvania Public School Employees Retirement System held 24,072 shares of Neurocrine Biosciences worth $4.06M as of Q2 2026.
Commonwealth of Pennsylvania Public School Employees Retirement System sold 1,074 Neurocrine Biosciences shares in Q2 2026, an estimated $159K.
Neurocrine Biosciences made up 0.02% of Commonwealth of Pennsylvania Public School Employees Retirement System's portfolio in Q2 2026, its #527 holding.
Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in Neurocrine Biosciences in Q2 2013 and has held it in 23 quarters since.
Commonwealth of Pennsylvania Public School Employees Retirement System's Neurocrine Biosciences position peaked at $5.17M in Q4 2022.
772 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Commonwealth of Pennsylvania Public School Employees Retirement System's 13F filing for Q2 2026, filed 17 Jul 2026.